YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
HKEX:1558.HK
8.19 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| 2,126.771 | 76.603 | -587.649 | 839.455 | 1,918.709 | 942.536 | 647.101 | 380.597 | 265.75 | 135.343 | 57.8 |
| Depreciation & Amortization
| 391.274 | 377.357 | 259.816 | 122.726 | 86.185 | 61.088 | 43.795 | 27.449 | 25.747 | 31.945 | 29.568 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 1,651.609 | 327.838 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 45.136 | 0 | 0 | 0 | 3.194 | 33.54 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -1,402.443 | -565.92 | -117.523 | 1,258.089 | -1,654.803 | -361.378 | -384.791 | -32.013 | -77.253 | -70.815 | -53.719 |
| Accounts Receivables
| -1,417.907 | -530.589 | -216.095 | 1,444.036 | -1,626.768 | -285.059 | -407.448 | -76.017 | -122.901 | -84.756 | -67.541 |
| Inventory
| -94.023 | -35.331 | 98.572 | -185.947 | -28.035 | -76.319 | 22.657 | 44.004 | 45.648 | 13.941 | 13.822 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 169.623 | 1,811.869 | -217.154 | -920.777 | -210.487 | -288.232 | 364.646 | 21.173 | 73.15 | 33.405 | 17.897 |
| Operating Cash Flow
| 1,673.212 | 1,699.909 | -662.51 | 1,299.493 | 1,794.407 | 715.392 | 670.751 | 397.206 | 287.394 | 129.878 | 51.546 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -595.078 | -570.07 | -356.285 | -994.159 | -576.276 | -620.039 | -327.036 | -62.987 | -28.004 | -35.47 | -76.438 |
| Acquisitions Net
| -12.6 | 0 | 0 | 0 | -78.159 | -352.989 | -137.402 | 202.826 | 0 | -3.186 | 0 |
| Purchases Of Investments
| -1,315.2 | -290 | 0 | 0 | -267.169 | -330 | -536.21 | -235.826 | -33 | 0 | 0 |
| Sales Maturities Of Investments
| 3,906.965 | 0 | 0 | 0 | 267.169 | 682.989 | 416.882 | 33 | 0 | 0 | 0 |
| Other Investing Activites
| -1,490.519 | -260.091 | -82.821 | -1,100.469 | -1,056.048 | -108.491 | -28.605 | -101.896 | -282.571 | 0.315 | 3.82 |
| Investing Cash Flow
| 554.568 | -1,120.161 | -439.106 | -2,094.628 | -1,710.483 | -728.53 | -612.371 | -367.709 | -343.575 | -38.341 | -72.618 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -1,339.855 | -1,146.161 | -157.678 | -1.25 | -311.663 | -10 | -70 | -105 | -270 | -462.94 | -133.21 |
| Common Stock Issued
| 0 | 0 | 0 | 138.167 | 557.622 | 0 | 19.344 | 1.984 | 1,613.481 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -136.917 | -245.959 | 0 | 50.656 | 103.016 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | -219.99 | -720.034 | -316.416 | -316.416 | -67.623 | 0 | 0 | 0 |
| Other Financing Activities
| -35.45 | 359.134 | 345.157 | 284.623 | 2,820.053 | 41.965 | -4.394 | -29.989 | -20.203 | 425.59 | -111.007 |
| Financing Cash Flow
| -1,476.899 | -787.027 | 187.479 | 64.633 | 2,100.019 | -284.451 | -371.466 | -200.628 | 1,323.278 | -37.35 | 22.203 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -0.011 | -0.299 | 0.291 | -3.669 | 1.449 | 4.152 | -11.803 | 29.552 | 0 | 0 | 31.236 |
| Net Change In Cash
| 750.87 | -207.578 | -913.846 | -734.171 | 2,185.392 | -293.437 | -324.889 | -141.579 | 1,267.097 | 54.187 | 32.367 |
| Cash At End Of Period
| 1,674.413 | 923.543 | 1,131.121 | 2,044.967 | 2,779.138 | 593.746 | 887.183 | 1,212.072 | 1,353.651 | 86.554 | 32.367 |